[Chest pain, dyspnea, syncope]. 1995

I Laube, and T C Medici, and R Jenni, and W Vetter
Departement Innere Medizin, Universitätsspital Zürich.

We report about the history of a 53-year-old female who suffered from dyspnea as well as leg and chest pain for six months; in addition she experienced two syncopal events. Recurrent pulmonary embolism was suspected, which was subsequently confirmed by positive scintigraphical findings. Acute cor pulmonale may have caused the syncopes. Therapy with heparin and oral warfarin was started. Within few days the patients condition improved markedly. Signs of pulmonary hypertension disappeared within five months.

UI MeSH Term Description Entries
D006976 Hypertension, Pulmonary Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. Pulmonary Hypertension
D007866 Leg The inferior part of the lower extremity between the KNEE and the ANKLE. Legs
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011655 Pulmonary Embolism Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS. Pulmonary Thromboembolism,Thromboembolism, Pulmonary,Embolism, Pulmonary,Embolisms, Pulmonary,Pulmonary Embolisms,Pulmonary Thromboembolisms,Thromboembolisms, Pulmonary
D002637 Chest Pain Pressure, burning, or numbness in the chest. Precordial Catch,Precordial Catch Syndrome,Texidor's Twinge,Chest Pains,Pain, Chest,Pains, Chest,Syndrome, Precordial Catch,Texidor Twinge
D004417 Dyspnea Difficult or labored breathing. Orthopnea,Platypnea,Recumbent Dyspnea,Rest Dyspnea,Trepopnea,Breathlessness,Shortness of Breath,Breath Shortness,Dyspnea, Recumbent,Dyspnea, Rest,Dyspneas, Rest
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses
D014859 Warfarin An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one,Aldocumar,Apo-Warfarin,Coumadin,Coumadine,Gen-Warfarin,Marevan,Tedicumar,Warfant,Warfarin Potassium,Warfarin Sodium,Potassium, Warfarin,Sodium, Warfarin

Related Publications

I Laube, and T C Medici, and R Jenni, and W Vetter
October 1995, Praxis,
I Laube, and T C Medici, and R Jenni, and W Vetter
February 1999, Der Internist,
I Laube, and T C Medici, and R Jenni, and W Vetter
July 2013, Mayo Clinic proceedings,
I Laube, and T C Medici, and R Jenni, and W Vetter
October 1963, Postgraduate medicine,
I Laube, and T C Medici, and R Jenni, and W Vetter
May 1989, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
I Laube, and T C Medici, and R Jenni, and W Vetter
September 2006, Canadian family physician Medecin de famille canadien,
I Laube, and T C Medici, and R Jenni, and W Vetter
April 2024, Pediatric pulmonology,
I Laube, and T C Medici, and R Jenni, and W Vetter
October 2000, Lancet (London, England),
I Laube, and T C Medici, and R Jenni, and W Vetter
November 2007, Revue medicale suisse,
I Laube, and T C Medici, and R Jenni, and W Vetter
March 2011, Praxis,
Copied contents to your clipboard!